INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 58 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $70,000 | – | 10,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMS Capital Management | 435,988 | $1,766,000 | 1.77% |
| WELCH & FORBES LLC | 508,649 | $2,060,000 | 0.06% |
| Hayek Kallen Investment Management | 12,015 | $49,000 | 0.03% |
| Indiana Trust & Investment Management CO | 13,250 | $54,000 | 0.03% |
| FLAGSHIP HARBOR ADVISORS, LLC | 16,007 | $62,000 | 0.02% |
| BOSTON FINANCIAL MANGEMENT LLC | 61,675 | $250,000 | 0.02% |
| HYMAN CHARLES D | 30,000 | $121,000 | 0.02% |
| Baker Brothers Advisors | 400,000 | $1,620,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 90,650 | $367,000 | 0.00% |
| GUGGENHEIM CAPITAL LLC | 243,781 | $987,000 | 0.00% |